Evidence map›Paper›PMID 34944109›Full record

ReviewCells2021

Aurora A and AKT Kinase Signaling Associated with Primary Cilia.

Yuhei Nishimura, Daishi Yamakawa, Takashi Shiromizu, Masaki Inagaki

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yuhei NishimuraDepartment of Integrative Pharmacology, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.ORCID 0000-0003-1901-8799
Daishi YamakawaDepartment of Physiology, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.
Takashi ShiromizuDepartment of Integrative Pharmacology, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.
Masaki InagakiGlocal Research Center for Advanced Medical Science, Mie University, Tsu 514-8507, Japan.
Mie University · JP

Funding

Japan Society for the Promotion of Science KAKENHI 19K07318 to YN, 20K07356 to DY, 18K06890 to TS, and 21H02696 to MI
6 · The paper itself

Abstract

Dysregulation of kinase signaling is associated with various pathological conditions, including cancer, inflammation, and autoimmunity; consequently, the kinases involved have become major therapeutic targets. While kinase signaling pathways play crucial roles in multiple cellular processes, the precise manner in which their dysregulation contributes to disease is dependent on the context; for example, the cell/tissue type or subcellular localization of the kinase or substrate. Thus, context-selective targeting of dysregulated kinases may serve to increase the therapeutic specificity while reducing off-target adverse effects. Primary cilia are antenna-like structures that extend from the plasma membrane and function by detecting extracellular cues and transducing signals into the cell. Cilia formation and signaling are dynamically regulated through context-dependent mechanisms; as such, dysregulation of primary cilia contributes to disease in a variety of ways. Here, we review the involvement of primary cilia-associated signaling through aurora A and AKT kinases with respect to cancer, obesity, and other ciliopathies.

Indexed as

Signal TransductionAnimalsAurora Kinase ACiliaHumansModels, BiologicalProto-Oncogene Proteins c-aktAurora Kinase AProto-Oncogene Proteins c-aktAKT kinaseaurora kinase Acancerciliopathydifferentiationlipid raftobesityprimary ciliumproliferationtrichoplein

Identifiers

PMID34944109
PMCPMC8699881
OpenAlexW4200216564

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.